Primrose Bio intends to apply its broad competencies in nucleic acid synthesis and protein expression to provide novel manufacturing solutions to these molecules as well. By offering affordable ...

Direct chemical synthesis has been adapted to make oligonucleotides of remarkable length, including an 800 nucleotide green ...

The resulting RNA molecule, typically mRNA, carries the genetic message from the nucleus to the cytoplasm for protein synthesis. Nucleic acids are the foundation of genetic engineering techniques, ...

Participants may access the live webcast on the Codexis Investor Relations website, where it will be archived for 90 days. The live call can be accessed by dialing 877-705-2976 (domestic) or ...

Although the government had published guidelines for researchers working with recombinant DNA technology, they had yet to provide any guidance that was specific to DNA synthesis companies or the ...

The acquisition will expand Maravai and TriLink BioTechnologies' ability to enable customers to develop next-generation mRNA and CRISPR nucleic acid-based therapies. “Molecular Assemblies is the ...

TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has partnered with, ...

Guanine is also a component of important biomolecules such as GTP (guanosine triphosphate), which is involved in cellular signaling and protein synthesis. In addition to their role in nucleic acids, ...

Nucleic acids like RNA not only stored genetic information ... likely created ideal conditions for RNA synthesis, explaining how volcanic islands on early Earth could have been the cradle for ...

SAN DIEGO - Maravai LifeSciences, Inc. (NASDAQ: MRVI), a $796 million market cap company known for supplying life science reagents and services, has announced the acquisition of intellectual property ...

This distribution partnership is expected to improve the ordering process and offer shorter lead times for European customers -- increasing access to TriLink’s novel nucleic acid technologies.